MedMira Inc. (MIR.V)
-TSXV | Prev Close: | 0.06 |
|---|
| Open: | 0.06 |
|---|
| Bid: | 0.05 |
|---|
| Ask: | 0.06 |
|---|
| 1y Target Est: | 11.85 |
|---|
| Beta: | N/A |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 0.05 - 0.06 |
|---|
| 52wk Range: | 0.03 - 0.07 |
|---|
| Volume: | 8,289 |
|---|
| Avg Vol (3m): | 45,246 |
|---|
| Market Cap: | 21.57M |
|---|
| P/E (ttm): | 3.44 |
|---|
| EPS (ttm): | 0.02 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
Quotes delayed, except where indicated otherwise. Currency in CAD.
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 14.01 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-10)
: | N/A |
|---|
| Quarterly EPS Est
(Dec-10)
: | N/A |
|---|
| Mean Recommendation*: | 2.8 |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
MedMira Inc., a biotechnology company, engages in the research, development, manufacture, and sale of rapid diagnostics and technology platforms. Its products include Reveal HIV, which detects antibodies to HIV-1 and HIV-2 in whole blood, serum, o...
View More 
0.12%